Literature DB >> 8719042

Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.

J Peter1, H Burbach, R A Adan, S J Lolait, F W van Leeuwen, E Mezey, M Palkovits, C Barberis.   

Abstract

1. VP and OT mediate their wealth of effects via 4 receptor subtypes V1a, V1b, V2, and OT receptors. 2. We here review recent insights in the pharmacological properties, structure activity relationships, species differences in ligand specificity, expression patterns, and signal transduction of VP/OT receptor. 3. Furthermore, the existence of additional VP/OT receptor subtypes is discussed.

Mesh：

Substances：

Year:  1995        PMID： 8719042     DOI： 10.1007/BF02071318

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN： 0272-4340            Impact factor:   5.046


  84 in total

1.  Structure and expression of a human oxytocin receptor.

Authors:  T Kimura; O Tanizawa; K Mori; M J Brownstein; H Okayama
Journal:  Nature       Date:  1992-04-09       Impact factor: 49.962

2.  Oxytocin and vasopressin: distinct receptors in myometrium.

Authors:  G Guillon; M N Balestre; J M Roberts; S P Bottari
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

3.  Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells.

Authors:  Y Granot; E Erikson; H Fridman; V Van Putten; B Williams; R W Schrier; J L Maller
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

4.  Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis.

Authors:  J P Burbach; J L Lebouille
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

5.  Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: relation to adenylate cyclase activation.

Authors:  G Guillon; D Butlen; B Cantau; T Barth; S Jard
Journal:  Eur J Pharmacol       Date:  1982-12-03       Impact factor: 4.432

6.  Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP4-9, in rat brain.

Authors:  E R de Kloet; T A Voorhuis; J P Burbach; D de Wied
Journal:  Neurosci Lett       Date:  1985-05-01       Impact factor: 3.046

7.  Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate.

Authors:  I Zachary; J Sinnett-Smith; E Rozengurt
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

8.  Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography.

Authors:  E Tribollet; C Barberis; S Jard; M Dubois-Dauphin; J J Dreifuss
Journal:  Brain Res       Date:  1988-02-23       Impact factor: 3.252

9.  Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.

Authors:  D M Dorsa; M D Brot; L M Shewey; K M Meyers; P Szot; M A Miller
Journal:  Synapse       Date:  1988       Impact factor: 2.562

10.  Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding.

Authors:  M M Rosenkilde; M Cahir; U Gether; S A Hjorth; T W Schwartz
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157
View more
  18 in total

1.  Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis.

Authors:  J Chen; G Aguilera
Journal:  J Neuroendocrinol       Date:  2010-10       Impact factor: 3.627

Review 2.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

3.  V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.

Authors:  L Gouzénes; N Sabatier; P Richard; F C Moos; G Dayanithi
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

4.  The Impact of Oxytocin Gene Knockout on Sexual Behavior and Gene Expression Related to Neuroendocrine Systems in the Brain of Female Mice.

Authors:  Josi Maria Zimmermann-Peruzatto; Virgínia Meneghini Lazzari; Grasiela Agnes; Roberta Oriques Becker; Ana Carolina de Moura; Renata Padilha Guedes; Aldo Bolten Lucion; Silvana Almeida; Márcia Giovenardi
Journal:  Cell Mol Neurobiol       Date:  2016-08-24       Impact factor: 5.046

5.  Oxytocin stimulates secretory processes in lactating rabbit mammary epithelial cells.

Authors:  Vanessa Lollivier; Pierre-Guy Marnet; Serge Delpal; Dominique Rainteau; Caroline Achard; Aline Rabot; Michèle Ollivier-Bousquet
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

6.  Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

Authors:  C Serradeil-Le Gal; C Lacour; G Valette; G Garcia; L Foulon; G Galindo; L Bankir; B Pouzet; G Guillon; C Barberis; D Chicot; S Jard; P Vilain; C Garcia; E Marty; D Raufaste; G Brossard; D Nisato; J P Maffrand; G Le Fur
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

7.  Oxytocin receptors in the primate ovary: molecular identity and link to apoptosis in human granulosa cells.

Authors:  S Saller; L Kunz; G A Dissen; R Stouffer; S R Ojeda; D Berg; U Berg; A Mayerhofer
Journal:  Hum Reprod       Date:  2010-01-23       Impact factor: 6.918

8.  Anti-apoptotic actions of vasopressin in H32 neurons involve MAP kinase transactivation and Bad phosphorylation.

Authors:  Jun Chen; Simona Volpi; Greti Aguilera
Journal:  Exp Neurol       Date:  2008-03-10       Impact factor: 5.330

Review 9.  Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.

Authors:  Verónica Bisagno; Jean Lud Cadet
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

Review 10.  Vasopressin V1B Receptor Antagonists as Potential Antidepressants.

Authors:  Shigeyuki Chaki
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.